| 1 |
Fournier PE, Richet H. The epidemiology and control of acinetobacter baumannii in health care facilities[J]. Clin Infect Dis, 2006, 42(5): 692-699.
|
| 2 |
Garnacho-Montero J, Timsit JF. Managing acinetobacter baumannii infections[J]. Curr Opin Infect Dis, 2019, 32(1): 69-76.
|
| 3 |
Munoz-Price LS, Weinstein RA. Acinetobacter infection[J]. N Engl J Med, 2008, 358(12): 1271-1281.
|
| 4 |
Dexter C, Murray GL, Paulsen IT, et al. Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis[J]. Expert Rev Anti Infect Ther, 2015, 13: 567-573.
|
| 5 |
Eliseo A. Community-acquired pneumonia infections by Acinetobacter baumannii: how does alcohol impact the antimicrobial functions of macrophages？[J]. Virulence, 2013, 4(6): 435-436.
|
| 6 |
Ong CW, Lye DC, Khoo KL, et al. Severe community-acquired acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific[J]. Respirology, 2009, 14(8): 1200-1205.
|
| 7 |
Eveillard M, Kempf M, Belmonte O, et al. Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections[J]. Int J Infect Dis, 2013, 17(10): e802-805.
|
| 8 |
Falagas ME, Karveli EA, Kelesidis I, et al. Community-acquired Acinetobacter infections[J]. Eur J Clin Microbiol Infect Dis, 2007, 26(12): 857-868.
|
| 9 |
Chen MZ, Hsueh PR, Lee LN, et al. Severe community-acquired pneumonia due to Acinetobacter baumannii[J]. Chest J, 2001, 120(4): 1072-1077.
|
| 10 |
王 涛，王瑞兰. 医院获得性鲍曼不动杆菌感染危险因素分析[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(2): 200-203.
|
| 11 |
张 鹏，周燕斌，黄炎明，等. 多重耐药鲍曼不动杆菌医院获得性肺炎的危险因素及预后分析[J]. 中国感染与化疗杂志，2015, 15(6): 527-532.
|
| 12 |
Chen CT, Wang YC, Kuo SC, et al. Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study[J]. J Microbiol Immunol Infect, 2018, 51(5): 629-635.
|
| 13 |
Davis JS, Mcmillan M, Swaminathan A, et al. A 16-year prospective study of community-onset bacteremic Acinetobacter pneumonia: low mortality with appropriate initial empirical antibiotic protocols[J]. Chest, 2014, 146(4): 1038-1045.
|
| 14 |
Lee YT, Kuo SC, Yang SP, et al. Bacteremic nosocomial pneumonia caused by Acinetobacter baumannii and Acinetobacter nosocomialis: a single or two distinct clinical entities？[J]. Clin Microbiol Infect, 2013, 19(7): 640-645.
|
| 15 |
Kuo SC, Lee YT, Yang SP, et al. Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia[J]. Clin Microbiol Infect, 2013, 19(7): 634-639.
|
| 16 |
Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality[J]. Medicine (Baltimore), 1995, 74(6): 340-349.
|